• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Doubling down on diabetes drugs, Eli Lilly invests $450M into Research Triangle Park facility

cafead

Administrator
Staff member
  • cafead   Jan 24, 2023 at 06:42: PM
via Eli Lilly will invest $450 million into its Research Triangle Park facility in North Carolina to boost manufacturing for its diabetes products, the company announced Tuesday.

article source